Bacillus Calmette-Guerin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma

被引：6
|
作者：
Aznar Martinez, Laura [1 ]
Lopez Cubillana, Pedro [1 ]
Lopez Abadb, Alicia [2 ]
Vidal Crespo, Natalia [1 ]
Gomez Gomez, Guillermo Antonio [1 ]
机构：
[1] Virgen de la Arrixaca Clin Univ Hosp, Dept Urol, Enrique Gallego 17, ES-30120 Murcia, Spain
[2] Univ Murcia, Dept Urol, Murcia, Spain
来源：
UROLOGIA INTERNATIONALIS | 2019年 / 103卷 / 02期
关键词：
Nonmuscle invasive bladder cancer; Immunosuppressed; Kidney transplant; Treatment; RENAL-TRANSPLANT RECIPIENTS; TRANSITIONAL-CELL CARCINOMA; CANCER;
D O I：
10.1159/000501108
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Due to their immunosuppressed status, solid organ transplant recipients are a special group of patients with an incidence of bladder cancer greater than the rest of the population, especially in the first 6 years after transplantation. Also, treatment with Bacillus Calmette-Guerin, a reference therapy in nonmuscle invasive high-risk bladder cancer, may be less effective in this group of patients and could cause more adverse effects. However, the data published so far and the experience initiated in the Virgen de la Arrixaca Clinical University Hospital do not support these hypotheses. (C) 2019 S. Karger AG, Basel
引用
收藏
页码：242 / 244
页数：3
相关论文
共 50 条
  • [31] Genomic analysis of response to bacillus Calmette-Guerin treatment in high-grade stage 1 bladder cancer patients
    Sanders, J. Alexa
    Frasier, Connor
    Matulay, Justin T.
    Steuerwald, Nury M.
    Zhu, Jason
    Grigg, Claud M.
    Kearns, James T.
    Riggs, Stephen B.
    Gaston, Kris E.
    Brouwer, Cory R.
    Burks, R. Tucker
    Hartman, Aaron L.
    Foureau, David M.
    Burgess, Earle F.
    Clark, Peter E.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (07) : 2998 - +
  • [32] The Challenge of Bacillus Calmette-Guerin Failure in Nonmuscle Invasive Bladder Cancer-What is the Next Step in Management?
    Lotan, Yair
    JOURNAL OF UROLOGY, 2013, 190 (03): : 832 - 833
  • [33] Cost-Effectiveness of Maintenance bacillus Calmette-Guerin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer EDITORIAL COMMENT
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2020, 204 (03): : 449 - 449
  • [34] Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guerin Treatment
    Lenis, Andrew T.
    Asanad, Kian
    Blaibel, Maher
    Donin, Nicholas M.
    Chamie, Karim
    UROLOGY PRACTICE, 2018, 5 (02) : 132 - 137
  • [35] Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure
    Juvet, Tristan
    Mari, Andrea
    Lajkosz, Katherine
    Wallis, Christopher J. D.
    Kuk, Cynthia
    Erlich, Annette
    Krimus, Lior
    Fleshner, Neil E.
    Kulkarni, Girish S.
    Zlotta, Alexandre R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (11) : 850.e9 - 850.e15
  • [36] A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer.
    Escano, De Jesus Manuel R.
    Sjoberg, Daniel D.
    McCarter, Melissa
    McGill, Marlena
    Goh, Alvin
    Donahue, Timothy F.
    Donat, Machele S.
    Cha, Eugene K.
    Herr, Harry W.
    Meraney, Anoop M.
    Al-Ahmadie, Hikmat A.
    Solit, David B.
    Dalbagni, Guido
    Bajorin, Dean F.
    Bochner, Bernard H.
    Pietzak, Eugene J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [37] Does the strain of bacillus calmette-guerin (BCG) used for intravesical instillations in the treatment of nonmuscle invasive transitional cell carcinoma of the bladder matter?
    Thalmann, George N.
    Birkhaeuser, Frederic
    Rentsch, Cyrill A.
    Ochsner, Katharina
    Studer, Urs E.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 522 - 522
  • [38] T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guerin Failure and Improves Patient Stratification at Diagnosis
    de Jong, Florus C.
    Hoedemaeker, Robert F.
    Kvikstad, Vebjorn
    Mensink, Jolien T. M.
    de Jong, Joep J.
    Boeve, Egbert R.
    van der Schoot, Deric K. E.
    Zwarthoff, Ellen C.
    Boormans, Joost L.
    Zuiverloon, Tahlita C. M.
    JOURNAL OF UROLOGY, 2021, 205 (03): : 701 - 708
  • [39] How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guerin Is Unavailable
    Witjes, Johannes Alfred
    Brausi, Maurizio
    Malmstrom, Per-Uno
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (05): : 705 - 709
  • [40] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
12345